315 related articles for article (PubMed ID: 29760016)
1. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
[TBL] [Abstract][Full Text] [Related]
2. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
[TBL] [Abstract][Full Text] [Related]
3. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats.
Durak A; Bitirim CV; Turan B
Cardiovasc Drugs Ther; 2020 Aug; 34(4):487-501. PubMed ID: 32377826
[TBL] [Abstract][Full Text] [Related]
4. Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts.
Kötter S; Gout L; Von Frieling-Salewsky M; Müller AE; Helling S; Marcus K; Dos Remedios C; Linke WA; Krüger M
Cardiovasc Res; 2013 Sep; 99(4):648-56. PubMed ID: 23764881
[TBL] [Abstract][Full Text] [Related]
5. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy.
Krüger M; Babicz K; von Frieling-Salewsky M; Linke WA
J Mol Cell Cardiol; 2010 May; 48(5):910-6. PubMed ID: 20184888
[TBL] [Abstract][Full Text] [Related]
6. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.
Krüger M; Kötter S; Grützner A; Lang P; Andresen C; Redfield MM; Butt E; dos Remedios CG; Linke WA
Circ Res; 2009 Jan; 104(1):87-94. PubMed ID: 19023132
[TBL] [Abstract][Full Text] [Related]
8. Elastic titin properties and protein quality control in the aging heart.
Salcan S; Bongardt S; Monteiro Barbosa D; Efimov IR; Rassaf T; Krüger M; Kötter S
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118532. PubMed ID: 31421188
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4.
Hamdani N; Hervent AS; Vandekerckhove L; Matheeussen V; Demolder M; Baerts L; De Meester I; Linke WA; Paulus WJ; De Keulenaer GW
Cardiovasc Res; 2014 Dec; 104(3):423-31. PubMed ID: 25341892
[TBL] [Abstract][Full Text] [Related]
10. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness.
Hidalgo C; Hudson B; Bogomolovas J; Zhu Y; Anderson B; Greaser M; Labeit S; Granzier H
Circ Res; 2009 Sep; 105(7):631-8, 17 p following 638. PubMed ID: 19679839
[TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.
Michel K; Herwig M; Werner F; Špiranec Spes K; Abeßer M; Schuh K; Dabral S; Mügge A; Baba HA; Skryabin BV; Hamdani N; Kuhn M
JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33055420
[TBL] [Abstract][Full Text] [Related]
12. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death.
Rabkin SW; Tsang MY
Exp Physiol; 2008 Jul; 93(7):834-42. PubMed ID: 18344257
[TBL] [Abstract][Full Text] [Related]
13. Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load.
Leite-Moreira AM; Almeida-Coelho J; Neves JS; Pires AL; Ferreira-Martins J; Castro-Ferreira R; Ladeiras-Lopes R; Conceição G; Miranda-Silva D; Rodrigues P; Hamdani N; Herwig M; Falcão-Pires I; Paulus WJ; Linke WA; Lourenço AP; Leite-Moreira AF
Cardiovasc Res; 2018 Apr; 114(5):656-667. PubMed ID: 29401264
[TBL] [Abstract][Full Text] [Related]
14. Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation.
Hamdani N; Krysiak J; Kreusser MM; Neef S; Dos Remedios CG; Maier LS; Krüger M; Backs J; Linke WA
Circ Res; 2013 Feb; 112(4):664-74. PubMed ID: 23283722
[TBL] [Abstract][Full Text] [Related]
15. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
[TBL] [Abstract][Full Text] [Related]
16. Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
Cuijpers I; Papageorgiou AP; Carai P; Herwig M; Mügge A; Klein T; Hamdani N; Jones EAV; Heymans S
J Cell Mol Med; 2021 Jan; 25(2):729-741. PubMed ID: 33295687
[TBL] [Abstract][Full Text] [Related]
17. Titin-Based Cardiac Myocyte Stiffening Contributes to Early Adaptive Ventricular Remodeling After Myocardial Infarction.
Kötter S; Kazmierowska M; Andresen C; Bottermann K; Grandoch M; Gorressen S; Heinen A; Moll JM; Scheller J; Gödecke A; Fischer JW; Schmitt JP; Krüger M
Circ Res; 2016 Oct; 119(9):1017-1029. PubMed ID: 27650557
[TBL] [Abstract][Full Text] [Related]
18. Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function.
Li S; Liang M; Gao D; Su Q; Laher I
J Cardiovasc Transl Res; 2019 Oct; 12(5):404-414. PubMed ID: 30820865
[TBL] [Abstract][Full Text] [Related]
19. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
[TBL] [Abstract][Full Text] [Related]
20. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
